HIV 1 News and Research

RSS

Opinions: Call for African companies to engage in health goals; holistic approach to development

The serious health problems afflicting our continent significantly affect our economies, reducing productivity, creating gaps in the workforce, causing innumerable sick days and restricting growth in African businesses, First Lady of Rwanda Jeannette Kagame and CEO of Access Bank Plc Aigboje Aig-Imoukhuede, who both serve on the Friends of the Global Fund Africa board, write together in a East African opinion piece that calls upon the private sector to help bolster the work with African governments to improve health outcomes in Africa.

3 Nov 2010

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

GenMark Diagnostics, Inc. a provider of automated, multiplex molecular diagnostic testing systems, announced today that it has acquired a non-exclusive license to Innogenetics' Hepatitis C Virus (HCV) genotyping patent estate for the United States.

3 Nov 2010

Guardian's Katine project coverage concludes

The Guardian concluded its three-year Katine project in north-eastern Uganda, which "tracked the implementation of a development project focusing on five aspects of deprivation: health, education, water and sanitation, livelihoods and governance," the newspaper writes.

3 Nov 2010

Kenya first of four countries to launch UNICEF, partners initiative aimed at PMTCT of HIV

On Friday, UNICEF and the Kenyan government announced a partnership aimed at preventing mother-to-child transmission (PMTCT) of HIV by providing HIV-positive mothers with packs of medicines they can easily administer to themselves or their babies at home, IRIN/PlusNews reports.

2 Nov 2010

White House Health Advisor Emanuel visits U.S. government-funded health programs during 3-nation African trip

The global fight against malaria could cut prevalence rates of malaria to one in 20 fevers by 2017, Special Advisor on Health Policy to the Director of the White House Office of Management and Budget Ezekiel Emanuel said in an interview in Dakar, Senegal, Bloomberg reports.

2 Nov 2010

Media outlets look ahead to Obama's trip to India

Several media outlets looked ahead to President Barack Obama's scheduled visit to India later this week, as part of his Asia-Pacific tour.

2 Nov 2010

Progress made in universal access to HIV prevention, treatment and care under threat

A report issued today by the International AIDS Society, Universal Access: Right Here, Right Now documents the principal debates around universal access during the XVIII International AIDS Conference (AIDS 2010). The report also takes stock of progress to date and reveals the scale of the future challenge for HIV treatment and prevention at a time when new infections are outstripping those receiving treatment by five to two.

30 Oct 2010

New MBP solution helps provide lifesaving HIV-prevention medications to mothers and babies

The Elizabeth Glaser Pediatric AIDS Foundation is pleased to partner with UNICEF and other organizations in the roll-out of the Mother-Baby Pack (MBP), an innovative solution to help bring lifesaving HIV-prevention medications to mothers and babies.

30 Oct 2010

Recent releases in Global Health

Global Fund Will Make 'Every Possible Effort' To Raise Additional Resources: Although pledges to the Global Fund to Fight AIDS, Tuberculosis and Malaria at its recent replenishment meeting did not meet "the lowest estimate of demand," the Fund "will make every possible effort to raise the additional resources that we expect countries to request in the years ahead" through new donor recruitment and "innovative financing approaches," writes Executive Director Michael Kazatchkine in a Lancet comment

30 Oct 2010

Merck reports $342 million net income for 2010 third quarter

Merck & Co., Inc. today announced financial results for the third quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the third quarter of $0.85, which excludes purchase accounting adjustments, restructuring costs, merger-related expenses and a $950 million legal reserve.

29 Oct 2010

China CDC signs collaborative agreement with Hutchinson Cancer Research Center

The Chinese Center for Disease Control and Prevention (China CDC) and Fred Hutchinson Cancer Research Center today formalized an ongoing relationship by signing a collaboration agreement. It marks the first such agreement between the China CDC and a U.S. cancer research center.

29 Oct 2010

Scientists identify potential new treatment for Nipah and Hendra viruses

Scientists at Weill Cornell Medical College have identified a potential new treatment for the Nipah and Hendra viruses, two lethal and emerging viruses for which there is currently no treatment or vaccine available. The approach could also lead to new therapies for measles, mumps and the flu. The new research appears in today's edition of the prestigious journal Public Library of Science (PLoS) Pathogens.

29 Oct 2010

Parasitic disease inflicts damage to women's reproductive organs: Research

Faculty of Life Sciences at the University of Copenhagen shows that the parasitic disease, commonly known as snail fever, or schistosomiasis, almost eats its way into women's reproductive organs. Today researchers from all over the world are gathering in Copenhagen to find out what can be done to halt the disease which is affecting millions of women in Africa.

29 Oct 2010

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Pfizer Inc announced that the Japanese Ministry of Health, Labour and Welfare approved Lyrica (pregabalin) capsules for the treatment of peripheral neuropathic pain. This follows the recent approval in Japan of Lyrica for the treatment of postherpetic neuralgia on April 16, 2010. Lyrica is the first medication approved for peripheral neuropathic pain in Japan where it is co-promoted with Eisai Co., Ltd.

29 Oct 2010

Geron 2010 third quarter revenue increases from $494,000 to $546,000

Geron Corporation today reported financial results for the three and nine months ended September 30, 2010.

29 Oct 2010

Opinions: Defense, diplomacy, development; PMTCT in Africa; perils of DIY aid; cholera in Haiti

In a Foreign Affairs essay, Secretary of State Hillary Rodham Clinton writes of the need to elevate diplomacy and development alongside defense a 'smart power' approach to solving global problems.

29 Oct 2010

Tenofovir gel to prevent HIV transmission nearing approval

Anti HIV drug Tenofovir in its gel form is to be fast-tracked for approval by the US FDA. The announcement was made by Conrad, a nonprofit scientific organization based in Arlington, Virginia that works with reproductive health.

28 Oct 2010

Hemophiliacs, hepatitis and HIV: A magic cure gone wrong

The dark side of capitalism’s effect on the medical and pharmaceutical industries is chillingly exposed in Doctor Guilt? Benefits of Medical Treatment Compared with Hazards – A tradeoff (published by iUniverse), the provocative new nonfiction by Everett Winslow Lovrien, M.D.

28 Oct 2010

New nationwide initiative to conduct research on human immune system

A new nationwide research initiative has been launched to define changes in the human immune system's response to infection and vaccination using human rather than animal models, which could lead to better vaccines and other treatments. Baylor Research Institute (BRI), along with five other U.S.-based Human Immune Phenotyping Centers, will receive a total of $100 million over five years to conduct the research.

28 Oct 2010

Pharmasset's PSI-938 phase I monotherapy trial shows positive result for HCV treatment

Pharmasset, Inc. reported positive preliminary results today from its phase I monotherapy trial of PSI-352938 for the treatment of chronic hepatitis C (HCV). PSI-938 is a guanosine nucleotide analog polymerase inhibitor in development for the treatment of chronic HCV infection.

28 Oct 2010

HIV 1 News and Research

Opinions: Call for African companies to engage in health goals; holistic approach to development

GenMark receives non-exclusive license to Innogenetics' HCV genotyping patent estate

Guardian's Katine project coverage concludes

Kenya first of four countries to launch UNICEF, partners initiative aimed at PMTCT of HIV

White House Health Advisor Emanuel visits U.S. government-funded health programs during 3-nation African trip

Media outlets look ahead to Obama's trip to India

Progress made in universal access to HIV prevention, treatment and care under threat

New MBP solution helps provide lifesaving HIV-prevention medications to mothers and babies

Recent releases in Global Health

Merck reports $342 million net income for 2010 third quarter

China CDC signs collaborative agreement with Hutchinson Cancer Research Center

Scientists identify potential new treatment for Nipah and Hendra viruses

Parasitic disease inflicts damage to women's reproductive organs: Research

Pfizer announces approval of Lyrica capsules for peripheral neuropathic pain

Geron 2010 third quarter revenue increases from $494,000 to $546,000

Opinions: Defense, diplomacy, development; PMTCT in Africa; perils of DIY aid; cholera in Haiti

Tenofovir gel to prevent HIV transmission nearing approval

Hemophiliacs, hepatitis and HIV: A magic cure gone wrong

New nationwide initiative to conduct research on human immune system

Pharmasset's PSI-938 phase I monotherapy trial shows positive result for HCV treatment

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News